药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Forasartan
Peficitinib
The risk or severity of adverse effects can be increased when Idelalisib is combined with Peficitinib.
Forasartan
Voclosporin
The risk or severity of adverse effects can be increased when Idelalisib is combined with Voclosporin.
Forasartan
Pirarubicin
The risk or severity of adverse effects can be increased when Idelalisib is combined with Pirarubicin.
Forasartan
Ravulizumab
The risk or severity of adverse effects can be increased when Idelalisib is combined with Ravulizumab.
Forasartan
Ixekizumab
The risk or severity of adverse effects can be increased when Idelalisib is combined with Ixekizumab.
Forasartan
Tepoxalin
The risk or severity of adverse effects can be increased when Idelalisib is combined with Tepoxalin.
Forasartan
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Idelalisib is combined with Antilymphocyte immunoglobulin (horse).
Forasartan
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Idelalisib is combined with Peginterferon beta-1a.
Forasartan
Tixocortol
The risk or severity of adverse effects can be increased when Idelalisib is combined with Tixocortol.
Forasartan
Vilanterol
The risk or severity of adverse effects can be increased when Idelalisib is combined with Vilanterol.
Forasartan
Dinutuximab
The risk or severity of adverse effects can be increased when Idelalisib is combined with Dinutuximab.
Forasartan
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Idelalisib.
Forasartan
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Idelalisib.
Forasartan
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Idelalisib.
Forasartan
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Idelalisib.
Forasartan
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Idelalisib.
Forasartan
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Idelalisib.
Forasartan
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Idelalisib.
Forasartan
Bendamustine
The risk or severity of adverse effects can be increased when Bendamustine is combined with Idelalisib.
Forasartan
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Idelalisib.